Literature DB >> 1505330

Glycemic control in early IDDM. The Wisconsin Diabetes Registry.

C Allen1, D J Zaccaro, M Palta, R Klein, S C Duck, D J D'Alessio.   

Abstract

OBJECTIVE: A cohort (n = 277) was followed from diabetes diagnosis to evaluate longitudinal glycemic control, urinary C-peptide levels, and certain features of diabetes self-management. RESEARCH DESIGN AND METHODS: Unselected cases with IDDM, who were less than 30 yr of age, were identified at diagnosis from a 28-county area in Wisconsin. Subjects were asked to submit blood every 4 mo for GHb testing, to report aspects of diabetes self-management every 6 mo, and to collect a 24-h urine specimen 4 mo after diagnosis.
RESULTS: In the 1st yr of diabetes, the rate of increase (0.23%/mo) in GHb was significant for the cohort (P less than 0.001) and for almost all age and sex subgroups. In the 2nd yr, there was no significant rate of increase for the cohort as a whole (P greater than 0.10). Adolescent males (10-19 yr of age) had a mean GHb level for year 2 higher than males of other age-groups and higher than female adolescents (P less than 0.001). Adolescent males had a significant rate of increase in GHb for year 2 (P = 0.02), unlike all other age and sex subgroups. Adolescents had higher initial 24-h urine C-peptide levels than children less than 10 yr of age (P less than 0.01). During the 2nd yr of diabetes, the percentage of adolescent males reporting three or more insulin injections/day was lower than any other subgroup.
CONCLUSIONS: These data-suggest that glycemic control stabilizes during the 2nd yr of IDDM, except in adolescent males, and that this may be due partly to aspects of self-management.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505330     DOI: 10.2337/diacare.15.8.980

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  5 in total

1.  Accuracy of a new real-time continuous glucose monitoring algorithm.

Authors:  D Barry Keenan; Raymond Cartaya; John J Mastrototaro
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

2.  The trajectory of IGF-1 across age and duration of type 1 diabetes.

Authors:  Mari Palta; Tamara J LeCaire; Mona Sadek-Badawi; Victor M Herrera; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

3.  Different health behaviours and clinical factors associated with bone mineral density and bone turnover in premenopausal women with and without type 1 diabetes.

Authors:  Amber S Kujath; Lauretta Quinn; Mary E Elliott; Tamara J LeCaire; Neil Binkley; Andrea R Molino; Kirstie K Danielson
Journal:  Diabetes Metab Res Rev       Date:  2015-01-21       Impact factor: 4.876

4.  Factors Associated with Higher Pro-Inflammatory Tumor Necrosis Factor-α Levels in Young Women with Type 1 Diabetes.

Authors:  K K Danielson; R S Monson; T J LeCaire
Journal:  Exp Clin Endocrinol Diabetes       Date:  2016-03-23       Impact factor: 2.949

5.  Handling the transition of adolescents with diabetes: participant observations and interviews with care providers in paediatric and adult diabetes outpatient clinics.

Authors:  Carina Sparud Lundin; Ella Danielson; Ingbritt Ohrn
Journal:  Int J Integr Care       Date:  2007-02-15       Impact factor: 5.120

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.